December 2024 - Page 2 of 3 - BioMedWire (BMW)

ThursdayDec 12, 2024 10:00 am

Why Retirees Should Think Carefully Before Enrolling for Medical Advantage

Retirees have benefited a lot from the Medicare program since its inception in 1965. With the 2025 open enrollment period for the program approaching, some may be thinking about switching to a Medicare Advantage plan. While these plans may appeal to the masses with their low premiums, they aren’t the best choice for every individual. Below, we discuss things retirees need to consider before moving to Medicare Advantage, as well as why they may prefer to remain covered under Original Medicare. So, what should retirees know about Medicare Advantage? For starters, these plans have limited provider networks as they operate…

WednesdayDec 11, 2024 8:45 am

Adageis is Ramping Up Patient Care for All Healthcare Providers and Systems via a Powerful Patented AI-Centric Software

Adageis, with its virtual quality care manager and productivity suite, aims to improve healthcare delivery by helping providers streamline operations and increase revenue through value-based care metrics by implementing its patented ProActive Care Platform. Easily scalable and adaptable, the platform is designed to fit with the electronic medical record systems of any healthcare provider, regardless of size, locations or number of patients. A unique offering in the healthcare technology space, the ProActive Care Platform offers flexible integration, proactive efficiency and advanced predictive analysis capabilities. Adageis is targeting a share of the fast-growing healthcare AI market, which was valued at 19.27…

TuesdayDec 10, 2024 10:00 am

New Staging System Could Forecast How Quickly Parkinson’s Might Progress After Diagnosis

In the early stages of Parkinson’s disease, alpha-synuclein accumulates in the brain, damaging nerve cells that produce dopamine. Dopamine is a hormone that regulates movement. Its absence in the brain can cause movement problems, among other symptoms. Investigators believe that alpha-synuclein accumulates in the brain for years before patients begin presenting with symptoms. Alpha-synuclein is a protein that forms Lewy bodies, which scientists believe may be the cause of Parkinson’s. Following research from last year that found that this protein could be detected in living patients via cerebrospinal fluid, investigators decided to use biological indicators to help develop a more…

FridayDec 06, 2024 10:00 am

Cases of Parvovirus B19 Spike in the US

Parvovirus B19, often referred to as the B19 virus, is a seasonal respiratory viral illness that is transmitted through respiratory secretions from an infected individual’s sneezes or coughs, their blood or blood products, or through vertical transmission from a pregnant woman to her baby. Common symptoms include joint pain in adults and slapped cheek rash in kids. In persons with weakened immune systems and blood disorders, infection can lead to a low blood count. The disease may also heighten the risk of miscarriage early in pregnancy. Earlier in August, the CDC issued an advisory on the increase in cases of…

FridayDec 06, 2024 8:45 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Data Demonstrates Potential of Innovative Solutions to Revolutionize Cancer Care

Emerging therapies, advanced diagnostic tools and groundbreaking research are reshaping the fight against cancer. Calidi Biotherapeutics uses stem cells and cell-enveloping technologies to deliver virotherapy payloads that attack cancers and leave healthy cells untouched. RTNova is designed to address the limitations of traditional virotherapy by offering enhanced targeting, systemic delivery and immune system modulation. Cancer continues to be a leading cause of morbidity and mortality worldwide, affecting millions of lives every year. While advances in prevention, early detection and treatment have made strides in reducing the global cancer burden, innovation remains critical to achieving further breakthroughs. Emerging therapies, advanced diagnostic…

ThursdayDec 05, 2024 10:00 am

New Computational Model Explains Behavioral and Neural Differences in ASD

Autism spectrum disorder is a developmental and neurological disorder that affects how an individual communicates with others, interacts with them and behaves, as well as learns. Researchers have developed a new computational model to explain the behavioral and neural differences in autism spectrum disorder. The new model provides new insights into information processing in the brains of persons living with autism, which may in turn broaden the horizons of future studies. The model was designed by Oded Wertheimer and Dr. Yuval Hart from the Department of Psychology at The Hebrew University of Jerusalem. It focuses on the dynamic range, which…

WednesdayDec 04, 2024 9:30 am

Astiva Health Inc. Expecting to Build Upon This Year’s Performance with Significant Membership Boost in 2025

The company anticipates a 70% increase in membership in the upcoming year, growing the current number of members from 13,000 in June 2024 to 20,000 in 2025. The fourfold increase in membership reflects the growing demand for a change in approach to healthcare that combines innovative personalized strategies with a deep understanding of the served communities. The company has established a strong network of over 12,940 providers, enabling it to offer comprehensive care to its rapidly growing member base, especially in Southern California. Astiva Health, a fast-growing Medicare Advantage Prescription Drug (“MAPD”) health plan, dedicated to reshaping personalized and comprehensive…

TuesdayDec 03, 2024 2:30 pm

Adageis Is ‘One to Watch’

Adageis operates in the rapidly expanding AI healthcare market, projected by Fortune Business Insights to reach $490.96 billion by 2032. The ProActive Care Platform offers seamless integration with existing EMR systems, reducing adoption barriers for healthcare providers. Partnerships with prominent organizations, such as HealthyU Clinics, and its status as an AthenaHealth marketplace partner, demonstrate Adageis’ growing influence in the healthcare sector. The company’s AI-driven predictive analytics enhance patient care and operational efficiency, aligning with the industry’s shift toward value-based care models. Led by a seasoned leadership team with extensive experience in healthcare and technology, Adageis is well-equipped to navigate the evolving healthcare…

TuesdayDec 03, 2024 10:00 am

e-Commerce Sees New Record as Thanksgiving Shoppers Go All Out on Spending

2024 saw Thanksgiving sales increase, with mobile and e-commerce purchases hitting new highs. An analysis conducted by Adobe Analytics determined that by the end of November 28th, online consumers had spent $6.1 billion during Thanksgiving. This figure represents an 8.8% increase from 2023’s Thanksgiving sales. Adobe Digital Insights’ lead analyst Vivek Pandya stated that Cyber Week had started on a strong high, with huge discounts driving impulse shopping in categories like apparel and electronics. Cyber Week refers to the 5-day period which includes Thanksgiving, Black Friday and Cyber Monday. This year, Cyber Monday was on December 2nd. Salesforce, an e-commerce…

TuesdayDec 03, 2024 8:00 am

Annovis Bio Inc. (NYSE: ANVS) to Present Recent Achievements and 2025 Strategic Outlook During Upcoming Live Investor Webcast

The webcast led by Annovis’ Founder, President and CEO, Maria Maccecchini, Ph.D., will take place on Dec. 11, at 4:30 p.m. EST. Dr. Maccecchini will provide a comprehensive view of the company’s recent achievements along with strategic initiatives for 2025, followed by a Q&A session. The company recently received FDA clearance to proceed with a pivotal Phase 3 Alzheimer’s disease program for lead drug candidate buntanetap, set to begin in early 2025. Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), will hold a…